Cite
A phase lb study of pertuzumab, a recombinant humanised antibody to HER2, and docetaxel in patients with advanced solid tumours
MLA
Attard, G., et al. “A Phase Lb Study of Pertuzumab, a Recombinant Humanised Antibody to HER2, and Docetaxel in Patients with Advanced Solid Tumours.” Attard , G , Kitzen , JJEM , Blagden , SP , Fong , PC , Pronk , LC , Zhi , J , Zugmaier , G , Verweij , J , de Bono , JS & de Jonge , M 2007 , ’ A Phase Lb Study of Pertuzumab, a Recombinant Humanised Antibody to HER2, and Docetaxel in Patients with Advanced Solid Tumours ’ , British Journal of Cancer , Vol. 97 , No. 10 , Pp. 1338-1343 , 2007. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1313613188&authtype=sso&custid=ns315887.
APA
Attard, G., Kitzen, J. (Jos), Blagden, S., Fong, P., Pronk, L., Zhi, J., Zugmaier, G., Verweij, J., de Bono, J., & de Jonge, M. (2007). A phase lb study of pertuzumab, a recombinant humanised antibody to HER2, and docetaxel in patients with advanced solid tumours. Attard , G , Kitzen , JJEM , Blagden , SP , Fong , PC , Pronk , LC , Zhi , J , Zugmaier , G , Verweij , J , de Bono , JS & de Jonge , M 2007 , ’ A Phase Lb Study of Pertuzumab, a Recombinant Humanised Antibody to HER2, and Docetaxel in Patients with Advanced Solid Tumours ’ , British Journal of Cancer , Vol. 97 , No. 10 , Pp. 1338-1343 .
Chicago
Attard, G, JJEM (Jos) Kitzen, Sp Blagden, Pc Fong, Lc Pronk, J Zhi, G Zugmaier, Jaap Verweij, Js de Bono, and Maja de Jonge. 2007. “A Phase Lb Study of Pertuzumab, a Recombinant Humanised Antibody to HER2, and Docetaxel in Patients with Advanced Solid Tumours.” Attard , G , Kitzen , JJEM , Blagden , SP , Fong , PC , Pronk , LC , Zhi , J , Zugmaier , G , Verweij , J , de Bono , JS & de Jonge , M 2007 , ’ A Phase Lb Study of Pertuzumab, a Recombinant Humanised Antibody to HER2, and Docetaxel in Patients with Advanced Solid Tumours ’ , British Journal of Cancer , Vol. 97 , No. 10 , Pp. 1338-1343 . http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1313613188&authtype=sso&custid=ns315887.